Letter from BridgeBio regarding the Adrenas program which provides information about the first patient to receive Adrenas' investigational gene therapy. See letter here.
A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
BridgeBio affiliate, Adrenas Therapeutics, is enrolling adults in a gene therapy trial for classic CAH. https://clinicaltrials.gov/ct2/show/NCT04783181.
For more information, please visit Adrenas’ ADvance-CAH website at https://cahgenetherapy.com.